https://www.selleckchem.com/pr....oducts/thioflavine-s
0008. LVO (adjusted to antenatal glucocorticoid administration and illness severity) and RVO (adjusted to gestational age and illness severity) is dependent on GNAS c.393C T polymorphism so that in T/T homozygotes and C/T heterozygotes but not in C/C homozygotes LVO and RVO increase with dobutamine treatment, 24.5 (6.2-42.9) mL kg min per AUC of 100 μg L h, P = .0095 and 33.2 (12.1-54.3) mL kg min per AUC of 100 μg L h, P = .0025, respectively. In critically ill neonates, β1-AR Arg389Gly and GNAS c.393C T polymorphisms m
Like
Comment
Share
